Sector: Pharmaceuticals & Biotechnology
|Small Cap
Bajaj Healthcare Ltd.
₹302.20
₹301.10
₹310.40
₹272.35
₹608.90
Markets Today
Historical Performance
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 153.06 | 161.22 | 147.91 | 148.84 | 154.47 |
| Operating Expense | 130.38 | 130.54 | 120.96 | 124.33 | 142.72 |
| Operating Profit | 22.68 | 30.68 | 26.95 | 24.51 | 11.76 |
| Depreciation | 7.63 | 7.20 | 7.08 | 5.64 | 7.53 |
| Interest | 5.57 | 5.88 | 5.56 | 5.23 | 6.08 |
| Tax | -1.40 | 3.14 | 3.51 | 2.35 | 0.13 |
| Net Profit | -22.85 | 15.67 | 11.11 | 11.83 | 11.18 |
₹302.20
↗ Bullish Moving Average
5
↘ Bearish Moving Average
11
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 59.2 | 59.2 | 59.2 | 59.2 | 59.2 | 58.3 |
| FII | 1 | 1 | 1.1 | 1.1 | 1.2 | 2 |
| DII | 2.4 | 2.6 | 3.1 | 3 | 2.9 | 2.9 |
| Public | 37.4 | 37.2 | 36.6 | 36.7 | 36.7 | 36.8 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 30.54 K | 80.22 K | 38.07% |
| Week | 91.59 K | 2.06 L | 44.36% |
| 1 Month | 1.05 L | 2.22 L | 47.33% |
| 6 Month | 79.98 K | 1.99 L | 40.23% |
Benjamin Graham Value Screen
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Companies with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 19 Sep, 2025 | 1 | FINAL | 19 Sep, 2025 | Equity Share |
| 23 Sep, 2024 | 1 | FINAL | Equity Share | |
| 22 Sep, 2023 | 1 | FINAL | Equity Share | |
| 22 Sep, 2022 | 1.5 | FINAL | Equity Share | |
| 28 Sep, 2021 | 0.5 | FINAL | 29 Sep, 2021 | Equity Share |
| 28 Sep, 2021 | 0.5 | SPECIAL | 29 Sep, 2021 | Equity Share |
| 01 Dec, 2020 | 1.25 | INTERIM | 02 Dec, 2020 | Equity Share |
| 01 Dec, 2020 | 0.5 | SPECIAL | 02 Dec, 2020 | Equity Share |
| 19 Sep, 2018 | 1 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹492.90 | ₹6.40 | ₹131.01 | ₹13.79 | ₹559.75 | ₹852.80 |
| % Change | 1.27% | -2.14% | 0.71% | -0.86% | 0.46% | 0.53% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹287.68 | - | ₹502.55 | ₹1,630.02 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹14.88 | - | ₹57.92 | ₹140.92 |
| PE TTM | - | -1.50 | 34.50 | - | 28.10 | 34.70 |
| 1 Year Return | 24.95 | 544 | 4.98 | 51.43 | -21.64 | -3.98 |
| ROCE | 3.56 | -5.63 | - | - | 23.87 | 15.27 |
Valiant Laboratories Ltd.
₹ 78.00
+1.46%
Sigachi Industries Ltd.
₹ 20.34
-0.05%
Windlas Biotech Ltd.
₹ 784.40
-0.70%
Vineet Laboratories Ltd.
₹ 35.00
-1.69%
Solara Active Pharma Sciences Ltd.
₹ 556.00
+1.44%
Zim Laboratories Ltd.
₹ 99.45
-0.71%
Medico Remedies Ltd.
₹ 48.93
+2.28%
Dishman Carbogen Amcis Ltd.
₹ 198.45
+1.58%
Lasa Supergenerics Ltd.
₹ 8.07
+1.00%
Advanced Enzyme Technologies Ltd.
₹ 376.50
+0.36%
Ortin Global Ltd.
₹ 15.06
-
Brooks Laboratories Ltd.
₹ 56.41
+4.99%
RPG Life Sciences Ltd.
₹ 2243.00
-2.22%
Bafna Pharmaceuticals Ltd.
₹ 135.50
+0.35%
Alpa Laboratories Ltd.
₹ 67.85
-1.89%
SMS Pharmaceuticals Ltd.
₹ 371.45
-2.62%
Nectar Lifesciences Ltd.
₹ 12.03
-0.25%
Mangalam Drugs and Organics Ltd.
₹ 29.01
-1.36%
Indoco Remedies Ltd.
₹ 195.70
-1.70%
Ind-Swift Laboratories Ltd.
₹ 133.00
+0.92%
Lincoln Pharmaceuticals Ltd.
₹ 722.00
-1.65%
Panacea Biotec Ltd.
₹ 419.90
+0.32%
Medicamen Biotech Ltd.
₹ 268.35
-0.45%
By signing up I certify terms, conditions & privacy policy